News
BNR
5.30
+14.22%
0.66
Weekly Report: what happened at BNR last week (1111-1115)?
Weekly Report · 3d ago
Weekly Report: what happened at BNR last week (1104-1108)?
Weekly Report · 11/11 12:21
Weekly Report: what happened at BNR last week (1028-1101)?
Weekly Report · 11/04 12:15
Weekly Report: what happened at BNR last week (1021-1025)?
Weekly Report · 10/28 12:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 10/21 12:07
Weekly Report: what happened at BNR last week (1014-1018)?
Weekly Report · 10/21 11:59
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 10/15 12:08
Weekly Report: what happened at BNR last week (1007-1011)?
Weekly Report · 10/14 12:39
Why Aehr Test Systems Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Benzinga · 10/11 10:20
Burning Rock Biotech, Dizal announce NMPA approval for sunvozertinib CDx
TipRanks · 10/11 09:31
Reported Earlier, Burning Rock and Dizal Secure NMPA Approval For NGS-Based Companion Diagnostic For Lung Cancer In China
Benzinga · 10/11 05:54
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China
Barchart · 10/10 22:16
Weekly Report: what happened at BNR last week (0930-1004)?
Weekly Report · 10/07 12:24
Weekly Report: what happened at BNR last week (0923-0927)?
Weekly Report · 09/30 12:15
Burning Rock Biotech Announces Executive Changes
TipRanks · 09/27 13:47
Burning Rock CFO resigns
Seeking Alpha · 09/27 13:03
Burning Rock Announces The Resignation Of Mr. Leo Li As A Director And As The Co's CFO, Effective September 27, 2024; Concurrently, Ms. Xiaozhi Hu Will Be In Charge Of Financial Operations
Benzinga · 09/27 12:43
Burning Rock Biotech CFO Leo Li resigns
TipRanks · 09/27 12:40
BURNING ROCK BIOTECH LTD - XIAOZHI HU TO OVERSEE FINANCIAL OPERATIONS AT BURNING ROCK
Reuters · 09/27 12:37
More
Webull provides a variety of real-time BNR stock news. You can receive the latest news about Burning Rock Biotech Ltd through multiple platforms. This information may help you make smarter investment decisions.
About BNR
Burning Rock Biotech Ltd is a holding company mainly engaged in the next generation sequencing (NGS) based cancer therapy selection. The Company operates three segments. Central Laboratory Business segment is engaged in the sales of cancer therapy selection test to individual patients. In-Hospital Business segment is engaged in the sales of reagent kits and the provision of the facilitation services for the sale of laboratory equipment to hospitals. Pharma Research and Development Services segment provide services to companies primarily in relation to the development of targeted therapies and immunotherapies for various types of cancer, and to hospitals for their studies on cancer diagnosis and treatment. Its products include OncoScreen Plus and LungPlasma. Its NGS-based cancer therapy selection tests applicable to a broad range of cancer types, including lung cancer, prostate cancer, breast cancer and others. The Company mainly conducts its businesses in the China market.